Results 321 to 329 of about 212,467 (329)

Novel Agents on the Horizon for Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2009
exaly  

The history and future of targeting cyclin-dependent kinases in cancer therapy

Nature Reviews Drug Discovery, 2015
Erik S Knudsen
exaly  

Optogenetically controlled protein kinases for regulation of cellular signaling

Chemical Society Reviews, 2018
Anna V Leopold, Vladislav V Verkhusha
exaly  

Protein kinases — the major drug targets of the twenty-first century?

Nature Reviews Drug Discovery, 2002
Philip Cohen
exaly  

Tec kinases regulate T‐lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk

Immunological Reviews, 2009
Pamela L Schwartzberg
exaly  

p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases

Nature Reviews Drug Discovery, 2003
exaly  

The Landscape of Atypical and Eukaryotic Protein Kinases

Trends in Pharmacological Sciences, 2019
Georgi K Kanev, Chris De Graaf, Iwan J P De Esch   +2 more
exaly  

Kinases as therapeutic targets for heart failure

Nature Reviews Drug Discovery, 2003
exaly  

Volasertib. Serine/threonine-protein kinase PLK1 inhibitor, Oncolytic.

Drugs of the Future, 2012
openaire   +3 more sources